SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-764420
Filing Date
2016-11-09
Accepted
2016-11-09 16:32:53
Documents
57
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d272237d10q.htm 10-Q 633883
2 EX-31.1 d272237dex311.htm EX-31.1 5976
3 EX-31.2 d272237dex312.htm EX-31.2 5971
4 EX-32.1 d272237dex321.htm EX-32.1 5482
  Complete submission text file 0001193125-16-764420.txt   2831679

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20160930.xml EX-101.INS 461793
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20160930.xsd EX-101.SCH 34518
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20160930_cal.xml EX-101.CAL 55472
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20160930_def.xml EX-101.DEF 90909
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20160930_lab.xml EX-101.LAB 261321
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20160930_pre.xml EX-101.PRE 183079
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 161984681
SIC: 2834 Pharmaceutical Preparations